Key Market Indicator:
F&G: 26
25.008,50 NASDAQ · 47.547,01 DOW · 6.744,95 S&P · 4.164,13 Gold · 62,61 BRENT

One Community. One Spirit. N#1 Broker.
all asset classes · all possibilities

Switch View
© PR Newswire
28.10.2025
ISIN: US14070B1017

Capricor Therapeutics, Inc.
CAPR

LISTED

NASDAQ
Kuehn Law Encourages Investors of Capricor Therapeutics, Inc. to Contact Law Firm
News Preview
NEW YORK, Oct. 28, 2025 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Capricor Therapeutics, Inc. (NASDAQ: CAPR) breached their fiduciary duties to shareholders. ...
Themefolio
Profiler
Peergroup
© PR Newswire
28.10.2025
ISIN: US05370A1088

Avidity Biosciences Inc
RNA

LISTED

NASDAQ
Shareholder Alert: The Ademi Firm investigates whether Avidity Biosciences Inc. is obtaining a Fair Price for its Public Shareholders
News Preview
MILWAUKEE, Oct. 28, 2025 /PRNewswire/ -- The Ademi Firm is investigating Avidity (Nasdaq: RNA) for possible breaches of fiduciary duty and other violations of law in its transaction with Novartis....
Themefolio
Profiler
Peergroup
© PR Newswire
28.10.2025
ISIN: US6404911066

Neogen Corp
NEOG

LISTED

NASDAQ
Kuehn Law Encourages Investors of Neogen Corporation to Contact Law Firm
News Preview
NEW YORK, Oct. 28, 2025 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Neogen Corporation (NASDAQ: NEOG) breached their fiduciary duties to shareholders....
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar

USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Short sale statistics, hedge fund activities and much more user-friendly information
© BusinessWire
28.10.2025
ISIN: US68622V1061

Organon & Co
OGN

LISTED

NYSE
Organon Investigation Initiated By Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates Claims On Behalf of Investors of Organon & Co. - OGN
News Preview
Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), is investigating claims on behalf of investors of Organon & Co. (NYSE: OGN). Such investors are advised to contact KSF Managing Partner Lewis Kahn toll-free at 1-877-515-1850 or via email (lewis.kahn@ksfcounsel.com...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© PR Newswire
28.10.2025
ISIN: US5165441032

Lantheus Holdings Inc
LNTH

LISTED

NASDAQ
Johnson Fistel Announces Class Action Lawsuit Against Lantheus Holdings, Inc. (LNTH) on Behalf of Investors
News Preview
DENVER, Oct. 28, 2025 /PRNewswire/ -- Johnson Fistel, PLLP announces that a class action lawsuit has commenced on behalf of investors of Lantheus Holdings, Inc. (NASDAQ: LNTH). The lawsuit seeks to recover losses on behalf of investors who purchased the Company's securities between February 26, 2025 and August 5,...
Themefolio
Profiler
Peergroup
© BusinessWire
28.10.2025
ISIN: US0718131099

Baxter International, Inc.
BAX

LISTED

NYSE
Law Offices of Frank R. Cruz Encourages Baxter International, Inc. (BAX) Shareholders to Inquire About Securities Fraud Class Action
News Preview
The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of shareholders who purchased Baxter International, Inc. (“Baxter” or the “Company”) (NYSE: BAX) common stock between February 23, 2022 and July 30, 2025, inclusive (the “Class Period”). Baxter investors have until December 15, 2025 to file a lead plain...
Themefolio
Profiler
Peergroup
© BusinessWire
28.10.2025
ISIN: KY61559X1045

MoonLake Immunotherapeutics
MLTX

LISTED

NASDAQ
Law Offices of Frank R. Cruz Encourages MoonLake Immunotherapeutics (MLTX) Shareholders to Inquire About Securities Fraud Class Action
News Preview
The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of shareholders who purchased MoonLake Immunotherapeutics (“MoonLake” or the “Company”) (NASDAQ: MLTX) common stock between March 10, 2024 and September 29, 2025, inclusive (the “Class Period”). MoonLake investors have until December 15, 2025 to file a...
Themefolio
Profiler
Peergroup
© Globe Newswire
28.10.2025
ISIN: FR0010259150

Ipsen SA
IPN

LISTED

EURONEXT
IPSEN - Buy-back programme - Art 5 of MAR - Week 43 - 2025
News Preview
Attachment...
Themefolio
Profiler
Peergroup
© BusinessWire
28.10.2025
ISIN: CNE100003PG4

Pharmaron Beijing Co., Ltd.
3759

LISTED

HKSE
Pharmaron Acquires Biortus in China
News Preview
Pharmaron Beijing Co., Limited (Stock Code: 300759.SZ/3759.HK) (hereinafter referred to as “Pharmaron” and the “Company”) today announced that it has entered into a definitive Share Purchase Agreement to acquire 82.54% equity interest of Biortus Biosciences Co., Ltd. and its affiliates (hereinafter referred to as "Biortus"). The transaction is exp...
Themefolio
Profiler
Peergroup
© PR Newswire
28.10.2025
ISIN: US3724463027

Genprex, Inc.
GNPX

LISTED

NASDAQ
Genprex Announces Registered Direct Offering of up to $10.0 Million Priced At-The-Market Under Nasdaq Rules
News Preview
$3.4 million upfront with up to an additional $6.6 million of potential aggregate gross proceeds upon the exercise in full of short-term warrants AUSTIN, Texas, Oct. 28, 2025 /PRNewswire/ -- Genprex, Inc. ("Genprex" or the...
Themefolio
Profiler
Peergroup
© EQS Newswire
28.10.2025
ISIN: DE000A0LD6E6

Gerresheimer AG
GXI

LISTED

XETR
Uwe Röhrhoff takes over as interim CEO for Dietmar Siemssen 
News Preview
Gerresheimer: Uwe Röhrhoff takes over as interim CEO for Dietmar Siemssen  Industry expert with many years of experience in the sector, including around 26 years in management positions at Gerresheimer Dietmar Siemssen to step down as CEO by mutual agreement with the Supervisory Board New formation of the Management Board Duesseldorf, October 2......
Themefolio
Profiler
Peergroup
© EQS Newswire
28.10.2025
ISIN: DE000A0LD6E6

Gerresheimer AG
GXI

LISTED

XETR
Uwe Röhrhoff übernimmt als Interims-CEO für Dietmar Siemssen
News Preview
Gerresheimer: Uwe Röhrhoff übernimmt als Interims-CEO für Dietmar Siemssen Industrieexperte mit langjähriger Branchenerfahrung, darunter rund 26 Jahre aus Managementpositionen bei Gerresheimer Dietmar Siemssen legt im Einvernehmen mit dem Aufsichtsrat sein Amt als CEO nieder Personelle Neuaufstellung des Vorstands Düsseldorf, 28. Oktober 2025. ......
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© EQS Newswire
28.10.2025
ISIN: DE000A0LD6E6

Gerresheimer AG
GXI

LISTED

XETR
Uwe Röhrhoff übernimmt als Interims-CEO für Dietmar Siemssen
News Preview
Gerresheimer AG: Uwe Röhrhoff übernimmt als Interims-CEO für Dietmar Siemssen Düsseldorf, 28. Oktober 2025. Der Aufsichtsrat der Gerresheimer AG (ISIN: DE000A0LD6E6, "Gerresheimer"), hat Uwe Röhrhoff mit Wirkung zum 1. November 2025 als Interims-CEO in den Vorstand der Gesellschaft berufen. Er folgt auf Dietmar Siemssen, der sein Amt als CEO der ......
Themefolio
Profiler
Peergroup
© EQS Newswire
28.10.2025
ISIN: DE000A0LD6E6

Gerresheimer AG
GXI

LISTED

XETR
Uwe Röhrhoff takes over as interim CEO for Dietmar Siemssen
News Preview
Gerresheimer AG: Uwe Röhrhoff takes over as interim CEO for Dietmar Siemssen  Duesseldorf, October 28, 2025. The Supervisory Board of Gerresheimer AG (ISIN: DE000A0LD6E6, "Gerresheimer") has appointed Uwe Röhrhoff as the interim CEO of the Management Board, effective November 1, 2025. He succeeds Dietmar Siemssen, who will step down as CEO of Ger......
Themefolio
Profiler
Peergroup
© BusinessWire
28.10.2025
ISIN: US81684M1045

Semler Scientific Inc
SMLR

LISTED

NASDAQ
SMLR Deadline Today: Rosen Law Firm Encourages Semler Scientific, Inc. Investors to Secure Counsel Before Important October 28 Deadline in Securities Class Action First Filed by the Firm – SMLR
News Preview
Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Semler Scientific, Inc. (NASDAQ: SMLR) between March 10, 2021 and April 15, 2025, both dates inclusive (the “Class Period”), of the important October 28, 2025 lead plaintiff deadline in the securities class action first filed by the Firm. So what: If you...
Themefolio
Profiler
Peergroup
© BusinessWire
28.10.2025
ISIN: US03828A1016

Applied Therapeutics Inc
APLT

LISTED

NASDAQ
Halper Sadeh LLC Encourages Applied Therapeutics, Inc. Shareholders to Contact the Firm to Discuss Their Rights
News Preview
Halper Sadeh LLC, an investor rights law firm, is investigating whether certain officers and directors of Applied Therapeutics, Inc. (NASDAQ: APLT) breached their fiduciary duties to shareholders. If you currently own Applied stock and are a long-term shareholder, you may be able to seek corporate governance reforms, the return of funds back to...
Themefolio
Profiler
Peergroup
© PR Newswire
28.10.2025
ISIN: KYG4403H1002

Hbm Holdings Limited
2142

LISTED

HKSE
Harbour BioMed Launches First Fully Human Generative AI HCAb Model to Accelerate Next-Generation Biologics Discovery
News Preview
CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, Oct. 28, 2025 /PRNewswire/ -- Harbour BioMed (HKEX: 02142), a global biopharmaceutical company focused on the discovery and development of novel antibody therapeutics in immunology and oncology, today announced the launch of its first fully human Generative A...
Themefolio
Profiler
Peergroup
© Globe Newswire
28.10.2025
ISIN: US67092M2089

Nutriband Inc.
NTRB

LISTED

NASDAQ
REPEAT — Nutriband Announces Successful Meeting Completed With United States FDA For Its Abuse Deterrent Fentanyl Patch
News Preview
Positive FDA meeting...
Themefolio
Profiler
Peergroup
© PR Newswire
28.10.2025
ISIN: US30161Q1040

Exelixis Inc
EXEL

LISTED

NASDAQ
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Exelixis, Inc. - EXEL
News Preview
NEW YORK, Oct. 28, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of  Exelixis, Inc. ("Exelixis" or the "Company") (NASDAQ: EXEL). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980....
Themefolio
Profiler
Peergroup
© PR Newswire
28.10.2025
ISIN: US5171251003

Larimar Therapeutics Inc
LRMR

LISTED

NASDAQ
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Larimar Therapeutics, Inc. - LRMR
News Preview
NEW YORK, Oct. 28, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Larimar Therapeutics, Inc. ("Larimar" or the "Company") (NASDAQ: LRMR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980....
Themefolio
Profiler
Peergroup
© PR Newswire
28.10.2025
ISIN: US83086J2006

Skye Bioscience Inc
SKYE

LISTED

NASDAQ
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Skye Bioscience, Inc. - SKYE
News Preview
NEW YORK, Oct. 28, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Skye Bioscience, Inc. ("Skye" or the "Company") (NASDAQ: SKYE). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980....
Themefolio
Profiler
Peergroup
© PR Newswire
28.10.2025
ISIN: US0144421072

Alector Inc
ALEC

LISTED

NASDAQ
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Alector, Inc. - ALEC
News Preview
NEW YORK, Oct. 28, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of  Alector, Inc. ("Alector" or the "Company") (NASDAQ: ALEC). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980....
Themefolio
Profiler
Peergroup
© PR Newswire
28.10.2025
ISIN: US8753721047

Tandem Diabetes Care Inc
TNDM

LISTED

NASDAQ
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Tandem Diabetes Care, Inc. - TNDM
News Preview
NEW YORK, Oct. 28, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of  Tandem Diabetes Care, Inc. ("Tandem" or the "Company") (NASDAQ: TNDM). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980....
Themefolio
Profiler
Peergroup
© PR Newswire
28.10.2025
ISIN: US0718131099

Baxter International, Inc.
BAX

LISTED

NYSE
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Baxter International, Inc. of Class Action Lawsuit and Upcoming Deadlines - BAX
News Preview
NEW YORK, Oct. 28, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Baxter International, Inc. ("Baxter" or the "Company") (NYSE: BAX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7...
Themefolio
Profiler
Peergroup
© PR Newswire
28.10.2025
ISIN: US81684M1045

Semler Scientific Inc
SMLR

LISTED

NASDAQ
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Semler Scientific, Inc. of Class Action Lawsuit and Upcoming Deadlines - SMLR
News Preview
NEW YORK, Oct. 28, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Semler Scientific, Inc. ("Semler" or the "Company") (NASDAQ: SMLR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7...
Themefolio
Profiler
Peergroup
© PR Newswire
28.10.2025
ISIN: US5324571083

Eli Lilly and Co
LLY

LISTED

NYSE
Lilly announces roster of Team USA athletes for the Olympic and Paralympic Games Milano Cortina 2026, pledges to translate U.S. Olympic and Paralympic milestones into meaningful community impact
News Preview
INDIANAPOLIS, Oct. 28, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced its roster of Team USA athletes for the Olympic and Paralympic Winter Games Milano Cortina 2026, reaffirming its mission to support athletes' holistic health and translate their achievements into meaningful impact for co...
Themefolio
Profiler
Peergroup
© PR Newswire
28.10.2025
ISIN: GB00BRS65X63

Indivior plc
INDV

LISTED

LSE
Indivior to Participate in the Stifel 2025 Healthcare Conference
News Preview
RICHMOND, Va., Oct. 28, 2025 /PRNewswire/ -- Indivior PLC (NASDAQ: INDV) today announced that it will participate in the Stifel 2025 Healthcare Conference:...
Themefolio
Profiler
Peergroup
© PR Newswire
28.10.2025
ISIN: KY61559X1045

MoonLake Immunotherapeutics
MLTX

LISTED

NASDAQ
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in MoonLake Immunotherapeutics of Class Action Lawsuit and Upcoming Deadlines - MLTX
News Preview
NEW YORK, Oct. 28, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against MoonLake Immunotherapeutics ("Moonlake" or the "Company") (NASDAQ: MLTX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free,...
Themefolio
Profiler
Peergroup
© PR Newswire
28.10.2025
ISIN: US0042251084

ACADIA Pharmaceuticals Inc
ACAD

LISTED

NASDAQ
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ACADIA Pharmaceuticals Inc. - ACAD
News Preview
NEW YORK, Oct. 28, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of  ACADIA Pharmaceuticals Inc. ("Acadia" or the "Company") (NASDAQ: ACAD). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980....
Themefolio
Profiler
Peergroup
© PR Newswire
28.10.2025
ISIN: US23282W6057

Cytokinetics Inc
CYTK

LISTED

NASDAQ
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Cytokinetics, Incorporate of Class Action Lawsuit and Upcoming Deadlines - CYTK
News Preview
NEW YORK, Oct. 28, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Cytokinetics, Incorporate ("Cytokinetics" or the "Company") (NASDAQ: CYTK). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free...
Themefolio
Profiler
Peergroup
© PR Newswire
28.10.2025
ISIN: US8051111016

Savara Inc
SVRA

LISTED

NASDAQ
Pomerantz Law Firm Announces the Filing of a Class Action Against Savara Inc. and Certain Officers - SVRA
News Preview
NEW YORK, Oct. 28, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Savara Inc. ("Savara" or the "Company") (NASDAQ: SVRA) and certain officers. The class action, filed in the United States District Court for the Eastern District of Pennsylvania, and docketed under 2...
Themefolio
Profiler
Peergroup
© PR Newswire
28.10.2025
ISIN: US5165441032

Lantheus Holdings Inc
LNTH

LISTED

NASDAQ
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Lantheus Holdings, Inc. of Class Action Lawsuit and Upcoming Deadlines - LNTH
News Preview
NEW YORK, Oct. 28, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Lantheus Holdings, Inc. ("Lantheus" or the "Company") (NASDAQ: LNTH). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext....
Themefolio
Profiler
Peergroup
© PR Newswire
28.10.2025
ISIN: US0021202025

Atyr Pharma, Inc.
ATYR

LISTED

NASDAQ
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in aTyr Pharma, Inc. of Class Action Lawsuit and Upcoming Deadlines - ATYR
News Preview
NEW YORK, Oct. 28, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against aTyr Pharma, Inc. ("aTyr" or the "Company") (NASDAQ: ATYR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Tho...
Themefolio
Profiler
Peergroup
© PR Newswire
28.10.2025
ISIN: US68621F1021

Organogenesis Holdings Inc
ORGO

LISTED

NASDAQ
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Organogenesis Holdings Inc. - ORGO
News Preview
NEW YORK, Oct. 28, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Organogenesis Holdings Inc. ("Organogenesis" or the "Company") (NASDAQ: ORGO). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980....
Themefolio
Profiler
Peergroup
© PR Newswire
28.10.2025
ISIN: US03969T1097

Arcturus Therapeutics Holdings Inc
ARCT

LISTED

NASDAQ
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Arcturus Therapeutics Holdings Inc. - ARCT
News Preview
NEW YORK, Oct. 28, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of  Arcturus Therapeutics Holdings Inc.  ("Arcturus" or the "Company") (NASDAQ: ARCT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980....
Themefolio
Profiler
Peergroup
© PR Newswire
28.10.2025
ISIN: US69608A1088

Palantir Technologies, Inc.
PLTR

LISTED

NASDAQ
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Palantir Technologies Inc. - PLTR
News Preview
NEW YORK, Oct. 28, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of  Palantir Technologies Inc.  ("Palantir" or the "Company") (NASDAQ: PLTR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980....
Themefolio
Profiler
Peergroup
© PR Newswire
28.10.2025
ISIN: US60855R1005

Molina Healthcare Inc
MOH

LISTED

NYSE
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Molina Healthcare, Inc. of Class Action Lawsuit and Upcoming Deadlines - MOH
News Preview
NEW YORK, Oct. 28, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Molina Healthcare, Inc. ("Molina" or the "Company") (NYSE: MOH).   Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 79...
Themefolio
Profiler
Peergroup
© PR Newswire
28.10.2025
ISIN: US44975P1030

I-Mab
IMAB

LISTED

NASDAQ
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of I-Mab - IMAB
News Preview
NEW YORK, Oct. 28, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of  I-Mab ("I-Mab" or the "Company") (NASDAQ: IMAB). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980....
Themefolio
Profiler
Peergroup
© PR Newswire
28.10.2025
ISIN: US8051111016

Savara Inc
SVRA

LISTED

NASDAQ
SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Savara
News Preview
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Savara To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Savara between March 7, 2024 and May 23, 202...
Themefolio
Profiler
Peergroup
© PR Newswire
28.10.2025
ISIN: KY61559X1045

MoonLake Immunotherapeutics
MLTX

LISTED

NASDAQ
SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of MoonLake Immunotherapeutics
News Preview
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In MoonLake To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in MoonLake between March 10, 2024 and Septem...
Themefolio
Profiler
Peergroup
© PR Newswire
28.10.2025
ISIN: US5165441032

Lantheus Holdings Inc
LNTH

LISTED

NASDAQ
SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Lantheus
News Preview
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Lantheus To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Lantheus between February 26, 2025 and Aug...
Themefolio
Profiler
Peergroup
© PR Newswire
28.10.2025
ISIN: US0718131099

Baxter International, Inc.
BAX

LISTED

NYSE
SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Baxter International
News Preview
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Baxter To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Baxter between February 23, 2022 and July 30...
Themefolio
Profiler
Peergroup
© BusinessWire
28.10.2025
ISIN: US28176E1082

Edwards Lifesciences Corp.
EW

LISTED

NYSE
Halper Sadeh LLC Encourages Edwards Lifesciences Corporation Shareholders to Contact the Firm to Discuss Their Rights
News Preview
Halper Sadeh LLC, an investor rights law firm, is investigating whether certain officers and directors of Edwards Lifesciences Corporation (NYSE: EW) breached their fiduciary duties to shareholders. If you currently own Edwards stock and are a long-term shareholder, you may be able to seek corporate governance reforms, the return of funds back t...
Themefolio
Profiler
Peergroup
© PR Newswire
28.10.2025
ISIN: US0021202025

Atyr Pharma, Inc.
ATYR

LISTED

NASDAQ
SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of aTyr Pharma
News Preview
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In aTyr To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in aTyr between January 16, 2025 and September 12...
Themefolio
Profiler
Peergroup
© PR Newswire
28.10.2025
ISIN: US1897631057

Co-Diagnostics Inc
CODX

LISTED

NASDAQ
Co-Diagnostics, Inc. Announces Pricing of $7.0 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules
News Preview
SALT LAKE CITY, Oct. 28, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced that it has entered into a securities purchase agreement with several in...
Themefolio
Profiler
Peergroup
© PR Newswire
28.10.2025
ISIN: US81684M1045

Semler Scientific Inc
SMLR

LISTED

NASDAQ
SMLR FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Investors of the Semler Scientific Upcoming Lead Plaintiff Deadline on Tuesday, October 28, 2025
News Preview
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Significant Losses In Semler Scientific To Contact Him Directly To Discuss Their Options If you suffered significant losses in Semler Scientific between...
Themefolio
Profiler
Peergroup
© PR Newswire
28.10.2025
ISIN: US1407553072

Tvardi Therapeutics Inc
TVRD

LISTED

NASDAQ
TVRD INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Tvardi Therapeutics
News Preview
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson  Encourages Investors Who Suffered Significant Losses In Tvardi To Contact Him Directly To Discuss Their Options...
Themefolio
Profiler
Peergroup
© BusinessWire
28.10.2025
ISIN: US92214X1063

Varex Imaging Corp
VREX

LISTED

NASDAQ
Varex Schedules Fourth Quarter and Fiscal Year 2025 Earnings Release and Conference Call
News Preview
Varex Imaging Corporation (Nasdaq: VREX) today announced that it will report unaudited financial results for the fourth quarter and fiscal year 2025, following the close of regular trading on Tuesday, November 18, 2025. The earnings news release will be followed by a conference call at 3:00 pm Mountain Time that day. This call will be webcast li...
Themefolio
Profiler
Peergroup
© PR Newswire
28.10.2025
ISIN: US53228F1012

LifeStance Health Group Inc
LFST

LISTED

NASDAQ
Calm Health Partners with LifeStance Health to Help Users Access High-Quality Mental Health Care
News Preview
Collaboration Will Simplify and Streamline Users' Ability to Find Personalized Care Delivered by Licensed Mental Health Clinicians PALO ALTO, Calif. and SCOTTSDALE, Ariz., Oct. 28, 2025 /PRNewswire/ -- Calm Health, Calm's evidence-based mental...
Themefolio
Profiler
Peergroup
© PR Newswire
28.10.2025
ISIN: KY61559X1045

MoonLake Immunotherapeutics
MLTX

LISTED

NASDAQ
Levi & Korsinsky Notifies Shareholders of MoonLake Immunotherapeutics(MLTX) of a Class Action Lawsuit and an Upcoming Deadline
News Preview
NEW YORK, Oct. 28, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in MoonLake Immunotherapeutics ("MoonLake" or the "Company") (NASDAQ: MLTX) of a class action securities lawsuit....
Themefolio
Profiler
Peergroup
© PR Newswire
28.10.2025
ISIN: US23282W6057

Cytokinetics Inc
CYTK

LISTED

NASDAQ
Levi & Korsinsky Reminds Cytokinetics Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of November 17, 2025 - CYTK
News Preview
NEW YORK, Oct. 28, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Cytokinetics, Incorporated ("Cytokinetics" or the "Company") (NASDAQ: CYTK) of a class action securities lawsuit....
Themefolio
Profiler
Peergroup
© PR Newswire
28.10.2025
ISIN: US0718131099

Baxter International, Inc.
BAX

LISTED

NYSE
Levi & Korsinsky Notifies Shareholders of Baxter International, Inc.(BAX) of a Class Action Lawsuit and an Upcoming Deadline
News Preview
NEW YORK, Oct. 28, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Baxter International, Inc. ("Baxter International, Inc." or the "Company") (NYSE: BAX) of a class action securities lawsuit....
Themefolio
Profiler
Peergroup
© BusinessWire
28.10.2025
ISIN: US88023B1035

Tempus AI, Inc.
TEM

LISTED

NASDAQ
Tempus to Participate in the Stifel 2025 Healthcare Conference
News Preview
Tempus AI, Inc. (NASDAQ: TEM), a leader in artificial intelligence and precision medicine, today announced that it will participate in the Stifel 2025 Healthcare Conference on Thursday, November 13 in New York City. Jim Rogers, Chief Financial Officer at Tempus, will participate in a fireside chat at 10:00 AM ET. The live webcast will be availab...
Themefolio
Profiler
Peergroup
© BusinessWire
28.10.2025
ISIN: US98978V1035

Zoetis Inc
ZTS

LISTED

NYSE
Zoetis Appoints Stephanie Tilenius to its Board of Directors
News Preview
Zoetis Inc. (NYSE: ZTS) today announced the appointment of Stephanie Tilenius to its Board of Directors, effective as of December 1, 2025. Ms. Tilenius brings extensive experience in technology-forward, digital health organizations to the Zoetis Board. Ms. Tilenius is a serial entrepreneur and has founded several healthcare companies, including...
Themefolio
Profiler
Peergroup
© EQS Newswire
28.10.2025
ISIN: CH0038389992

BB Biotech AG
BION

LISTED

SIX
Edison issues report on BB Biotech (BION)
News Preview
  London, UK, 28 October 2025   Edison issues report on BB Biotech (BION) Edison issues report on BB Biotech (SIX: BION) BB Biotech (BION) delivered strong Q325 results, underpinned by its focus on innovative biotech companies with differentiated clinical pipelines and promising long-term potential. NAV increased 24.0% (in CHF terms) and its s......
Themefolio
Profiler
Peergroup
© Newsfile
28.10.2025
ISIN: CA46604F1099

Izotropic Corporation
IZO

LISTED

CSE
Izotropic Launches "Breast Imaging News" Page on BreastCT.com
News Preview
Vancouver, British Columbia, and Sacramento, California--(Newsfile Corp. - October 28, 2025) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic", or the "Company"), a medical device company commercializing innovative, emerging technologies and imaging-based products for the more accurate screening, diagnoses, and treatment of...
Themefolio
Profiler
Peergroup
© BusinessWire
28.10.2025
ISIN: US03815U6073

Applied DNA Sciences, Inc.
BNBX

LISTED

NASDAQ
BNBX Launches Digital Asset Treasury Dashboard and Provides Corporate Update
News Preview
Applied DNA Sciences, Inc. (NASDAQ: BNBX) ( “BNBX” or the “Company”) today announced the launch of BNBX.io, which provides real-time portfolio metrics updating the market on the Company’s BNB treasury holdings, key valuation metrics, and detailed information about the capitalization structure of the Company (the “Dashboard”). This press release f...
Themefolio
Profiler
Peergroup
© BusinessWire
28.10.2025
ISIN: US04963C2098

AtriCure Inc
ATRC

LISTED

NASDAQ
AtriCure Announces the First Patient Treated in the BoxX-NoAF Clinical Trial
News Preview
AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management, today announced that the first patient was enrolled and treated in the Box Lesion Creation with Left Atrial Appendage Exclusion to Reduce the Occurrence o...
Themefolio
Profiler
Peergroup
© BusinessWire
28.10.2025
ISIN: US30052C1071

Evolus Inc
EOLS

LISTED

NASDAQ
Evolus to Participate in 2025 Stifel Healthcare Conference
News Preview
Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today announced members of its management team will participate in a fireside chat and investor meetings at the upcoming Stifel Healthcare Conference. The fireside chat will take place on Tuesday, November 11, 2025, at 11...
Themefolio
Profiler
Peergroup
© BusinessWire
28.10.2025
ISIN: US7140461093

Revvity Inc
RVTY

LISTED

NYSE
Revvity to Present at Upcoming Investor Conferences
News Preview
Revvity, Inc. (NYSE: RVTY), today announced it will present at the following investor conferences: UBS Global Healthcare Conference 2025 Monday, November 10, 2025 8:00 a.m. ET - Max Krakowiak, senior vice president and chief financial officer Jefferies 2025 London Healthcare Conference Tuesday, November 18, 2025 2:00 p.m. GMT – Max Krakowiak...
Themefolio
Profiler
Peergroup

More sector specific news

Your Press Release is missing or you want share news over GICS11? Drop us a line.

Gamechanger in online marketing · Innovation as a service · Upgrade your own internet presence.

© 2025 Select Sector SPDRs

* * *

More Sector related Investment Ideas
© 2025 WEBs Investments ETFs
About the newsfeed
#1
What types of information are provided on this portal - and what purpose does it serve?
The portal provides structured, stock market-relevant company information that is specifically assigned to a particular economic sector. The focus is on current announcements from official NewsWire sources, supplemented by company profiles, filter options by sector and sector-specific research aids. The aim is to offer an interested group of people a systematically structured research environment that improves their understanding of sector developments and corporate strategies.
#2
Why are companies categorized according to a certain system?
Financial markets consist of thousands of listed companies with very different business models. In order to create transparency and comparability, companies worldwide are assigned to standardized classifications. These classifications help investors to better analyze markets, identify sector-specific trends and make more targeted investment decisions.
#3
What classification standards exist for grouping companies?
There are various industry classifications that are used depending on the region or application. The best known include GICS (Global Industry Classification Standard), ICB (Industry Classification Benchmark), NAICS (North American Industry Classification System) and TRBC (Thomson Reuters Business Classification). Most institutional investors and ETFs worldwide use GICS or ICB as a benchmark.
#4
What classification standard is this financial information portal based on?
The portal uses the Global Industry Classification Standard (GICS), which was jointly developed by MSCI and S&P Dow Jones Indices. GICS is widely used in the institutional financial world and forms the basis for many global equity indices, ETFs and research systems.
#5
What exactly does GICS mean - and how is the system structured?
GICS stands for Global Industry Classification Standard. It is a hierarchical structure that divides listed companies worldwide into four levels: Sector, Industry Group, Industry Sector and Sub-Industry. In total, the system comprises 11 main sectors, over 60 industries and more than 150 sub-categories. It allows a consistent, internationally comparable analysis of economic activities.
#6
Why is GICS important in the financial world?
GICS offers a standardized language for investment decisions. It makes it possible to compare companies with similar business models - regardless of country, stock exchange or company size. Many investment funds, indices and research houses use GICS as a basis for portfolio construction, risk analysis or market screening. This means that it also makes sense for private investors to use this structure as a guide.
#7
Who decides which GICS sector a company is assigned to?
The allocation is made by the index providers MSCI and S&P Dow Jones on the basis of a company's main business segment. The decisive factor is the segment from which the company generates the majority of its sales or operating profit. Changes in the business model or strategic realignments can lead to a company being assigned to a different industry or even a different sector.
#8
What is meant by the GICS sector "Materials"?

The GICS "Materials" sector comprises companies that are active in the production, processing or refinement of raw materials. This includes industries such as chemicals, building materials, paper & forest products and the entire metallurgical and mining industry. The sector is highly cyclical and is particularly sensitive to economic fluctuations and changes in global demand.

#9
Which companies typically belong to the Materials sector?
Typical representatives are international groups from the areas of chemicals production (e.g. BASF), precious metal mining (e.g. Barrick Gold), building materials production (e.g. Heidelberg Materials) or industrial gases (e.g. Linde). The shares of these companies are often heavily dependent on commodity prices and play a central role in industrial value chains.
#10
Where does the company news on this page come from?
The news is based on verified and publicly available sources such as BusinessWire, GlobeNewswire, PR Newswire, EQS, Newsfile, ACCESSNewswire and other NewsWire services. These platforms are used by listed companies to publish mandatory ad hoc announcements, financial reports or strategic developments. All content is prepared in a structured manner and, if a corresponding categorization is possible, brought together in industry-specific clusters.
#11
How is the sector-specific mapping of messages carried out?
Categorization is based on structured metadata (e.g. ISIN, ticker, sector classification) and a combination of keyword analysis and GICS mapping. This ensures that all news is assigned to the correct sector and - if available - the correct sub-sector.
#12
Why is the materials sector particularly interesting for investors?
The Materials sector is closely linked to global industrial production and offers both cyclical growth opportunities and hedging opportunities against inflation and raw material shortages. In addition, many companies in this sector play a key role in future topics such as electromobility, the energy transition and sustainable building materials.
#13
What distinguishes this project from traditional financial information portals?
In contrast to generic portals, this project focuses exclusively and specifically on a particular sector. The advantage for interested investors: Sector-specific information, news, market movements and company profiles can be filtered and analyzed in a more targeted manner. This enables more in-depth research and greater relevance for thematic investment decisions.
#14
Are smaller companies also represented here or only large corporations?
The newsfeed takes into account both large caps and mid and small caps. As a clear mapping criterion is required in order to enable the most precise possible allocation to a cluster, the ISIN of the listed company is generally used for this purpose, provided that this can be made available or mapped via corresponding newsfeed parameters.
#15
How up-to-date are the displayed messages?
The content is updated regularly. The publication follows the publications of the information source, the NewsWire feeds of the underlying distributors. Incoming reports are automatically processed, classified and displayed on the page. Timestamps and source information ensure maximum transparency.
#16
Can I also filter the news by sub-sector?
Yes, this is a central feature of the site. Within a main sector, you can filter specifically for sub-sectors such as "Metals & Mining". For particularly popular industries or developments within a meta-sector, it is possible to deviate from standard clusters. Special categories with particular information value enable thematic analyses to be carried out even more precisely.
#17
Are there plans to process other metasectors in a similar way?
Yes, this financial information portal is part of an extensive project in which separate information portals are being created for all the main sectors. The aim is to provide investors with a systematic, sector-based research tool - regardless of index affiliation or provider perspective.
#18
Why do companies publish announcements via NewsWire services at all?
NewsWire services such as BusinessWire or PR Newswire fulfill a regulatory function: they enable companies to publish price-sensitive information publicly and without discrimination. In many countries, the use of such services is a prerequisite for fulfilling publication obligations under capital market law. They also enable companies to reach the media, analysts and investors in a targeted manner.
#19
Can private or inactive companies also appear in such notifications?
Generally not. The platform focuses exclusively on listed companies whose disclosures are based on regulatory requirements or corporate strategy measures. Although private or unlisted companies occasionally publish announcements, these are not systematically processed or classified here.
#20
What happens when a company changes its business model - does its sector classification also change?
Yes, as a rule - but not automatically. The responsible classification institutes (e.g. MSCI and S&P for GICS) regularly check the relevance and consistency of the classifications. If there is a significant change in a company's sales or profit profile, it may be reclassified to a different industry or even a different sector. This usually takes place after fixed review cycles or upon request.
#21
How is it ensured that a company is correctly categorized if it is active in several business areas?
The categorization is based on the dominant sales segment. If a company is active in several sectors but generates 70% of its turnover with chemical products, for example, it is assigned to the GICS sector "Materials" - even if it also has activities in the energy or transportation sector. In borderline cases, additional qualitative assessment criteria apply.
#22
Are there any legal risks in the further use of the displayed content?
The content comes from public sources, but is partially subject to copyright protection - particularly with regard to text structure and layout. The excerpts and links provided on this portal are made within the scope of permitted use (e.g. right to quote or editorial processing). However, commercial use by third parties is not permitted without the express permission of the original providers.
#23
Who can I contact if I have general questions or legal concerns?
A central contact point is available for general inquiries, information on company recordings, compliance issues or copyright-relevant aspects. In rare cases, for example in the case of erroneously published information or justified requests for deletion, a review and, if necessary, removal from the public feed can take place. Please only use the official contact option in the legal notice or at the bottom of the page.
#24
Is advertising or third-party content also displayed on the portal?
Yes, in defined areas the portal can display advertising content or product-specific information from third parties - for example on sector-related financial services, research offers or trading platforms. This content is clearly marked as advertising or partner information and is separate from the editorial or automatically processed company news.
#26
Can I give feedback on the platform or submit suggestions?
Absolutely - feedback is expressly welcome. The platform is an open information service that is continuously being developed. Comments on functionality, data quality, usability or thematic extensions help to optimize the service for the benefit of users. You can submit your suggestions informally via the contact page or special feedback forms.
#27
I am an information provider - can I cooperate with the portal?
Yes, the portal is open to content-related, technical or editorial cooperation, provided that this contributes to the quality, relevance or dissemination of the offering. If you offer content, interfaces or services that could be useful in the context of stock market-related information, we would be pleased to hear from you. The platform offers flexible integration options and a professional environment for quality-assured content.
#28
Can the platform technology also be used for other applications or partners?
Yes, the platform is based on a modular, scalable infrastructure that can be adapted to different information contexts and industry models. Technical components such as data aggregation, structuring logic, classification mechanisms and semantic filters can also be made available for external projects or individual applications on request. Please contact us for cooperation or license models.
#29
Can the underlying company data also be licensed or reused?
Structured access to selected master data of listed companies - such as GICS mapping, ISIN mapping, news feeds or metadata filters - is generally possible. The offer is aimed in particular at information service providers, research platforms or data-driven financial applications. Data can be provided via defined interfaces (e.g. API) or exportable formats, depending on the intended use and license framework.
#30
What forms of cooperation with external partners are conceivable?
Basically open. Possible forms of cooperation range from technical integrations and shared data models to content syndication or white label solutions. Partnerships with institutions that are looking for access to quality-assured data, dynamically structured news or sector-specific analyses - for example in the FinTech, media or research environment - are particularly interesting. We look forward to hearing from business development or product management departments.
#31
Why does this portal differ technically and conceptually from other information offerings?
Because no one from outside the industry is trying to understand the financial market here - but because the know-how comes from the heart of the financial world. The technical platform was developed by a team that combines in-depth market knowledge with innovative system design. The result: information architecture with real relevance, not shop window technology.
#32
What makes the technical solution particularly interesting for operators of their own financial portals?
In addition to high adaptability, the platform impresses with its modular structure and the consistent implementation of industry-specific logic - from GICS mapping to metadata filtering. For providers who operate their own information portals, sector-specific data structures, news feeds or visualizations can be quickly integrated on this basis - either as a white label, API module or embedded solution.
#33
Why can a collaboration go beyond traditional development services?
Because we don't just program, we think: The technological implementation is based on a deep understanding of market cycles, regulations, data formats and investor needs. Anyone who cooperates with this platform benefits from a sparring partner at eye level - both technically and professionally. This creates added value that goes far beyond pure IT expertise.
#34
Note on copyright and the processing of original content
The corporate news presented on this information portal is based on publicly accessible sources such as BusinessWire, GlobeNewswire, PR Newswire or comparable news services. The content is processed as part of an automated or editorially supported structuring process without changing, shortening or reinterpreting the content of the original information. This is so-called "as is" information, the form and content of which corresponds to the originally published announcement. The rights to the original texts remain unrestrictedly with the respective publishers or copyright holders. This portal merely assumes a structural categorization and allocation within the framework of a news-journalistic offer. Independent commercial reuse, systematic reproduction or other use of the content by third parties is only permitted within the framework of the statutory provisions or with the consent of the copyright holder.
About GICS Health
GICS Health is part of the GICS Eleven information portfolio, which focuses primarily on information from listed companies in the health sector. The sector classification serves as a guide to navigate quickly and conveniently through the latest industry-specific news. Individual peer group clusters complement the news offering.
About GICS Eleven

GICS Eleven (G11, GICS11) bundles topic-specific content and enables quick access to relevant information thanks to its gate function. The project is largely based on the Global Industry Classification Standard (GICS®), which was developed by MSCI and Standard & Poor's and enables a breakdown into sectors. GICS® consists of 11 sectors, 24 industry branches, 69 industries and 158 sub-industries.

GICS® is a registered trademark of MSCI Inc. and S&P Dow Jones Indices.

Member of 3R/RSQ Network
Digital Content
Network Alliance
Transparency - Reliability - Credibility
Information regarding Product Information
Thursday, 13.11.2025, Calendar Week 46, 317th day of the year, 48 days remaining until EoY.